CysLT1 Antagonist Q8

1541762-55-3 Basic information More..

Product Name:	CysLT1 Antagonist Q8
Synonyms:	CysLT1 Antagonist Q8;Q8 hydrochloride;Q8 hydrochloride,Q-8 hydrochloride
CAS:	1541762-55-3
MF:	C17H14ClNO2
MW:	299.75
EINECS:
Mol File:	1541762-55-3.mol

CysLT1 Antagonist Q8 manufacturers

Information Error Report

Your Email:

Browse by province 1541762-55-3 Suppliers

Beijing(1)

Shanghai(2)

Member(3)

All(3)

1541762-55-3 Recommend Suppliers

Recommend You Select Member Companies...

Company Name:	Shanghai EFE Biological Technology Co., Ltd. Recommend Complaint

Tel:	021-65675885
FAX:	021-65675885
Email:	info@efebio.com
Products Intro:	Product Name:CysLT1 Antagonist Q8 CAS:1541762-55-3 Purity:99% Package:10mg;25mg;50mg More...
CB Index:	58
WebSite:	http://www.efebio.com
Related Information:	Sales Network Catalog(9804) User Evaluation

Company Name:	TargetMol Chemicals Inc. Recommend Complaint

Tel:
FAX:
Email:	marketing@targetmol.cn
Products Intro:	Product Name:Q8 hydrochloride CAS:1541762-55-3 Package:1removed More...
CB Index:	58
WebSite:	https://www.targetmol.cn/
Related Information:	Sales Network Catalog(29845) User Evaluation

Company Name:	Biosynth Biological Technology (Suzhou) Co Ltd Recommend Complaint

Tel:
FAX:
Email:	sales@biosynth.com
Products Intro:	Product Name:Cyslt1 antagonist Q8 CAS:1541762-55-3 More...
CB Index:	58
WebSite:	www.biosynth.com
Related Information:	Sales Network Catalog(6051) User Evaluation

Tag: 1541762-55-3

HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.